![]() Washington Post | Pfizer Stops Developing Cholesterol Drug TheStreet.com - By TSC Staff. Pfizer (PFE - commentary - Cramer's Take) is halting development of Torcetrapib a cholesterol drug for which the company had high hopes. Pressures on Pfizer multiply as it ends development of key drug Pfizer Ends Studies on Drug for Treating Heart Disease |